
Featured
The GLP-1 Disruption and Regulatory Squeeze: A Structural Reckoning for the $50 Billion Fitness and Nutrition Industry
The convergence of aggressive FDA supplement enforcement and the widespread adoption of GLP-1 weight-loss drugs has triggered a structural contraction...
Read Full Story →
